Effect of increasing serum albumin on haemostatic factors synthesized in the liver in CAPD patients

Nephrology Dialysis Transplantation

Volumn 13, Issue 8, 1998, Pages 2053-2058

  Kim, Soon Bae ^a   Yang, Won Seok ^a   Lee, Sang Koo ^a   Chi, Hyun Sook ^a   Park, Jung Sik ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Albumin; CAPD; Factor VII; Fibrinogen

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 2 ANTIPLASMIN; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 7; C REACTIVE PROTEIN; FIBRINOGEN; PLASMINOGEN; PROTEIN C; PROTEIN S; PROTHROMBIN; SERUM ALBUMIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; FEMALE; HEMATOCRIT; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; FACTOR VII; FEMALE; FIBRINOGEN; HEMOSTASIS; HUMANS; LIVER; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; SERUM ALBUMIN;

EID: 0031870395     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.8.2053     Document Type: Article

References (22)

1. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Hypoalbuminemia, cardiac morbidity and mortality in end-stage renal disease. J Am Soc Nephrol 1996; 7: 728-736
2. Churchill DN, Taylor DW, Cook RJ et al. Canadian hemodialysis morbidity study. Am J Kidney Dis 1992; 19: 214-234
3. Llach F. Hypercoagulabilily, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int 1985; 28: 429-439
4. Bartens W, Nauck M, Schollmeyer P, Wanner C. Elevated lipoprotein(a) and fibrinogen serum levels increase the cardiovascular risk in continuous ambulatory peritoneal dialysis patients. Peril Dial Int 1996; 16: 27-33
5. Kim KJ, Yang WS, Kim SB, Lee SK, Park JS. Fibrinogen and fibrinolytic activity in CAPD patients with atherosclerosis and correlation with serum albumin. Perit Dial Int 1997; 17: 157-161
6. Edmunds LH, Salzman EW. Hemostatic problems, transfusion therapy, and cardiopulmonary bypass in surgical patients. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis. J. B. Lippincott Co., Philadelphia: 1994: 956-968
7. Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980; 33: 27-39
8. Vaziri ND, Shah GM, Winer RL et al. Coagulation cascade, fibrinolytic system, antihrombin III, protein C and protein S in patients maintained on continuous ambulatory peritoneal dialysis. Thromb Res 1989; 53: 173-180
9. Jones CL, Andrew M, Eddy A, O'Neil M, Shalom NI, Balfe JW. Coagulation abnormalities in chronic peritoneal dialysis. Pediatr Nephrol 1990; 4: 152-155
10. Cavagna R, Schiavon R, Tessarin C et al. Risk factors of ischemic cardiac disease in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 1993; 13 [suppl 2]: S402-405
11. Tomura S, Nakamura Y, Doi M et al. Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 1996; 27: 848-854
12. Lai KN, Yin JA, Yuen PM, Li PK. Protein C, protein S, and antithrombin III levels in patients on continuous ambulatory peritoneal dialysis and hemodialysis. Nephron 1990; 56: 271-276
13. Anderson S, Kennefick TM, Brenner BM. Renal and systemic manifestations of glomerular disease. In: Brenner BM, ed. The Kidney. W. B. Saunders, Philadelphia: 1996: 1981-2010
14. Vaziri ND, Gonzales EC, Wang J, Said S. Blood coagulation, fibrinolytic and inhibitory proteins in end-stage renal disease: Effect of hemodialysis. Am J Kidney Dis 1994; 23: 828-835
15. Kanfer A, Kleinknecht D, Broyer M, Josso F. Coagulation studies in 45 cases of nephrotic syndrome without uremia. Thromb Diathes Haemorrh 1970; 24: 562-571
16. Pickart LR, Thaler MM. Free fatty acids and albumin as mediators of thrombin-stimulated fibrinogen synthesis. Am J Physiol 1976; 230: 996-1002
17. Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991; 91: 191-205
18. Andersen P, Smith P, Seljeflot I, Brataker S. Arnesen H. Effects of gemfibrozil on lipids and haemostasis after myocardial infarction. Thromb Haemost 1990; 63: 174-177
19. Farmer JA, Gotto AM Jr. Dyslipidemia and other risk factors for coronary artery disease. In: Braunwald E, ed. Heart Disease. W. B. Saunders, Philadelphia: 1997: 1126-1160
20. Richard JL, Warnet JM, Ducimetiere P. Decreased levels of the albumin-alpha-1-globulin fraction of serum proteins, risk factor for ischemic cardiopathy. Rev Epidemiol Sante Publique 1985; 33: 347-351
21. Phillips A, Shaper AG, Whincup PH. Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet 1989; 2(8677): 1434-1436
22. Folsom AR, Ma J, Eckfeldt JH, Nieto FJ, Metcalf PA, Barnes RW. Low serum albumin. Association with diabetes mellitus and other cardiovascular risk factors but not with prevalent cardiovascular disease or carotid artery intima-media thickness. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Ann Epidemiol 1995; 5: 186-1891